These findings underscore the significance of WNT7A in HNSCC progression and propose the targeting of key molecules within the FZD7/JAK1/STAT3 pathway as a promising strategy for precise treatment of HNSCC. The gene discussed is FZD7; the disease is head and neck squamous cell carcinoma.